1-3 of 3
Mariana Nacht
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Target Engagement, Pathway Inhibition, and Efficacy Of The Bruton’s Tyrosine Kinase (Btk) Inhibitor CC-292

Daniel W Pierce, Sabine Ponader, PhD, Kumudha Balakrishnan, Varsha Gandhi, PhD, William G. Wierda, MD, Susan O'Brien, MD, Carla Heise, PhD, Mariana Nacht, PhD, Sharon Aslanian, Xiping Liu, Sean Hong, Shijuan Wu, Marianna Zavodovskaya, MS, Jeffrey Marine, Evelyn Barnett, Pilar Nava-Parada, Jay Mei, MD, Rajesh Chopra, MD, Jan A. Burger, MD, PhD, Juswinder Singh
Journal: Blood
Blood (2013) 122 (21): 4169.
https://doi.org/10.1182/blood.V122.21.4169.4169
Published: 2013
Journal Articles

Clinical Development of AVL-292; A Potent, Selective Covalent Btk Inhibitor for the Treatment of B Cell Malignancies,

Erica Evans, PhD, Richland Tester, PhD, Sharon Aslanian, Prasoon Chaturvedi, PhD, Hormoz Mazdiyasni, Sabine Ponader, PhD, Bethany Tesar, Michael Sheets, Mariana Nacht, PhD, Kathryn Stiede, Steve Witowski, PhD, Heather Lounsbury, Russell Petter, PhD, Jennifer R. Brown, MD, PhD, Jan A. Burger, MD, PhD, Juswinder Singh, PhD, William F. Westlin, PhD
Journal: Blood
Blood (2011) 118 (21): 3485.
https://doi.org/10.1182/blood.V118.21.3485.3485
Published: 2011
Journal Articles

Prolonged Inhibition of BCR Signaling and Suppression of B Cell Lymphoma through Irreversible Inhibition of Bruton’s Tyrosine Kinase

Erica Evans, Michael Sheets, Hugues Bernard, Thia St. Martin, Mariana Nacht, Rich Tester, Chuck Jewell, Hormoz Mazdiyasni, Russell Petter, William Westlin, Juswinder Singh
Journal: Blood
Blood (2008) 112 (11): 2608.
https://doi.org/10.1182/blood.V112.11.2608.2608
Published: 2008